

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 7.74544286 |
| 2 | complement activation, classical pathway (GO:0006958) | 6.68754831 |
| 3 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.89290258 |
| 4 | complement activation (GO:0006956) | 5.44713944 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.19214379 |
| 6 | antimicrobial humoral response (GO:0019730) | 5.14682573 |
| 7 | response to nitric oxide (GO:0071731) | 5.14374064 |
| 8 | antibacterial humoral response (GO:0019731) | 5.13495199 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.08458988 |
| 10 | regulation of guanylate cyclase activity (GO:0031282) | 5.07445860 |
| 11 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 5.06087011 |
| 12 | * regulation of dendritic cell antigen processing and presentation (GO:0002604) | 5.03805246 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.02691349 |
| 14 | positive regulation of respiratory burst (GO:0060267) | 5.02029677 |
| 15 | * regulation of cellular extravasation (GO:0002691) | 4.94457609 |
| 16 | NADH metabolic process (GO:0006734) | 4.83505197 |
| 17 | virion attachment to host cell (GO:0019062) | 4.52461578 |
| 18 | adhesion of symbiont to host cell (GO:0044650) | 4.52461578 |
| 19 | epoxygenase P450 pathway (GO:0019373) | 4.48375384 |
| 20 | glomerular filtration (GO:0003094) | 4.29841551 |
| 21 | intestinal absorption (GO:0050892) | 4.28849699 |
| 22 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.25111418 |
| 23 | peptide catabolic process (GO:0043171) | 4.23006100 |
| 24 | protein activation cascade (GO:0072376) | 4.22644436 |
| 25 | fructose metabolic process (GO:0006000) | 3.99948442 |
| 26 | * positive regulation of antigen processing and presentation (GO:0002579) | 3.95032642 |
| 27 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.90196414 |
| 28 | renal filtration (GO:0097205) | 3.87761106 |
| 29 | * regulation of antigen processing and presentation (GO:0002577) | 3.83400930 |
| 30 | adhesion of symbiont to host (GO:0044406) | 3.83282346 |
| 31 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.80291478 |
| 32 | endocrine process (GO:0050886) | 3.80291478 |
| 33 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.80291478 |
| 34 | hormone catabolic process (GO:0042447) | 3.70105430 |
| 35 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.63229365 |
| 36 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.62796725 |
| 37 | regulation of respiratory burst (GO:0060263) | 3.59887986 |
| 38 | humoral immune response (GO:0006959) | 3.59837647 |
| 39 | low-density lipoprotein particle remodeling (GO:0034374) | 3.53079269 |
| 40 | diacylglycerol metabolic process (GO:0046339) | 3.50328022 |
| 41 | ethanol oxidation (GO:0006069) | 3.48733372 |
| 42 | regulation of systemic arterial blood pressure (GO:0003073) | 3.48137358 |
| 43 | immunoglobulin mediated immune response (GO:0016064) | 3.38188273 |
| 44 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.37850877 |
| 45 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.34987192 |
| 46 | renal system process involved in regulation of blood volume (GO:0001977) | 3.34580037 |
| 47 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.31940311 |
| 48 | lipoprotein transport (GO:0042953) | 3.27693458 |
| 49 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.27459756 |
| 50 | germinal center formation (GO:0002467) | 3.26350956 |
| 51 | drug metabolic process (GO:0017144) | 3.25685115 |
| 52 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.24656102 |
| 53 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.24656102 |
| 54 | regulation of cGMP biosynthetic process (GO:0030826) | 3.23659500 |
| 55 | urea cycle (GO:0000050) | 3.21838755 |
| 56 | cellular response to nitric oxide (GO:0071732) | 3.18503542 |
| 57 | * positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.18129501 |
| 58 | cellular response to reactive nitrogen species (GO:1902170) | 3.16546519 |
| 59 | urea metabolic process (GO:0019627) | 3.10623875 |
| 60 | peptide hormone processing (GO:0016486) | 3.10557947 |
| 61 | endothelial cell chemotaxis (GO:0035767) | 3.07851804 |
| 62 | nitrogen cycle metabolic process (GO:0071941) | 3.06696312 |
| 63 | regulation of bile acid biosynthetic process (GO:0070857) | 3.06029725 |
| 64 | detection of bacterium (GO:0016045) | 3.04215155 |
| 65 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.02715445 |
| 66 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.99926398 |
| 67 | * positive regulation of glycoprotein metabolic process (GO:1903020) | 2.97206128 |
| 68 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.96864312 |
| 69 | sexual reproduction (GO:0019953) | 2.96578840 |
| 70 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.95433143 |
| 71 | regulation of integrin activation (GO:0033623) | 2.90667893 |
| 72 | protein-lipid complex remodeling (GO:0034368) | 2.89675421 |
| 73 | macromolecular complex remodeling (GO:0034367) | 2.89675421 |
| 74 | plasma lipoprotein particle remodeling (GO:0034369) | 2.89675421 |
| 75 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.88743791 |
| 76 | plasma lipoprotein particle assembly (GO:0034377) | 2.88092084 |
| 77 | * positive regulation of pseudopodium assembly (GO:0031274) | 2.86629010 |
| 78 | NIK/NF-kappaB signaling (GO:0038061) | 2.86031171 |
| 79 | regulation of vitamin metabolic process (GO:0030656) | 2.85955703 |
| 80 | phospholipid efflux (GO:0033700) | 2.84576973 |
| 81 | regulation of triglyceride catabolic process (GO:0010896) | 2.82438261 |
| 82 | * T cell costimulation (GO:0031295) | 2.78037962 |
| 83 | phospholipid scrambling (GO:0017121) | 2.77714020 |
| 84 | detection of other organism (GO:0098543) | 2.77345242 |
| 85 | actin filament depolymerization (GO:0030042) | 2.76722641 |
| 86 | lipoprotein metabolic process (GO:0042157) | 2.74691812 |
| 87 | * lymphocyte costimulation (GO:0031294) | 2.73693443 |
| 88 | cGMP-mediated signaling (GO:0019934) | 2.73654190 |
| 89 | lymph node development (GO:0048535) | 2.70163276 |
| 90 | regulation of cholesterol esterification (GO:0010872) | 2.69664348 |
| 91 | positive thymic T cell selection (GO:0045059) | 2.69254242 |
| 92 | protein-lipid complex assembly (GO:0065005) | 2.68696442 |
| 93 | plasma lipoprotein particle organization (GO:0071827) | 2.68469404 |
| 94 | leukotriene metabolic process (GO:0006691) | 2.65834393 |
| 95 | ethanol metabolic process (GO:0006067) | 2.62501953 |
| 96 | * dendritic cell chemotaxis (GO:0002407) | 2.61995292 |
| 97 | protein-lipid complex subunit organization (GO:0071825) | 2.59079216 |
| 98 | regulation of cGMP metabolic process (GO:0030823) | 2.58625693 |
| 99 | regulation of extracellular matrix disassembly (GO:0010715) | 2.58222039 |
| 100 | chronic inflammatory response (GO:0002544) | 2.58124586 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.61451904 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.40691749 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.93571528 |
| 4 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.11201150 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.03056828 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.91573811 |
| 7 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.83129752 |
| 8 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.55290065 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.46034560 |
| 10 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.30719589 |
| 11 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.24800840 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.09113045 |
| 13 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.04066498 |
| 14 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.03678035 |
| 15 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.03207316 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.95718339 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.90880445 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.81078714 |
| 19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.74480412 |
| 20 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.66752454 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.63345265 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.63242069 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.61113554 |
| 24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.56949320 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.55910763 |
| 26 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.55879617 |
| 27 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.52999752 |
| 28 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.52935491 |
| 29 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.52578395 |
| 30 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.52219017 |
| 31 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.51037856 |
| 32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47333179 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.46943588 |
| 34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.44670305 |
| 35 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.43718700 |
| 36 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41356065 |
| 37 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.40164046 |
| 38 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.36488229 |
| 39 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.36001453 |
| 40 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.34314416 |
| 41 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.31129590 |
| 42 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.29239865 |
| 43 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.28737340 |
| 44 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.28013778 |
| 45 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.27720978 |
| 46 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.26772641 |
| 47 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.25868804 |
| 48 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23584617 |
| 49 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.22914166 |
| 50 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.22856265 |
| 51 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22619324 |
| 52 | SA1_27219007_Chip-Seq_Bcells_Human | 1.21529673 |
| 53 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20250301 |
| 54 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.20184721 |
| 55 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.18860679 |
| 56 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.18513522 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17581989 |
| 58 | MYC_22102868_ChIP-Seq_BL_Human | 1.15733709 |
| 59 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15127492 |
| 60 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14432790 |
| 61 | UTX_26944678_Chip-Seq_JUKART_Human | 1.14267601 |
| 62 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14116009 |
| 63 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.12585555 |
| 64 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.10458017 |
| 65 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.09343300 |
| 66 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.07660483 |
| 67 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.07649085 |
| 68 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.07483338 |
| 69 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.07012087 |
| 70 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.06847499 |
| 71 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06712308 |
| 72 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.05447903 |
| 73 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04356110 |
| 74 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.03670075 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03193426 |
| 76 | MAF_26560356_Chip-Seq_TH1_Human | 1.00720200 |
| 77 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00550090 |
| 78 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00425543 |
| 79 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.99715750 |
| 80 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99162851 |
| 81 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98724503 |
| 82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98549643 |
| 83 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97845305 |
| 84 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.97619851 |
| 85 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96995377 |
| 86 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.96450699 |
| 87 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95698632 |
| 88 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.95208090 |
| 89 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95156878 |
| 90 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95118044 |
| 91 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.95036718 |
| 92 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.93134476 |
| 93 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92731087 |
| 94 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92669614 |
| 95 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.92661113 |
| 96 | MYB_26560356_Chip-Seq_TH1_Human | 0.92366523 |
| 97 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.89139880 |
| 98 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.88971459 |
| 99 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.88622247 |
| 100 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.88372360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.79702648 |
| 2 | MP0009379_abnormal_foot_pigmentation | 3.71428660 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.48169925 |
| 4 | MP0010155_abnormal_intestine_physiology | 3.26490869 |
| 5 | MP0001666_abnormal_nutrient_absorption | 3.14779660 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 2.96196842 |
| 7 | MP0009840_abnormal_foam_cell | 2.86633863 |
| 8 | MP0000685_abnormal_immune_system | 2.83875874 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 2.68705487 |
| 10 | MP0003183_abnormal_peptide_metabolism | 2.48670395 |
| 11 | MP0003724_increased_susceptibility_to | 2.46103930 |
| 12 | MP0005365_abnormal_bile_salt | 2.40943104 |
| 13 | MP0001873_stomach_inflammation | 2.40663684 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.35098498 |
| 15 | MP0004264_abnormal_extraembryonic_tissu | 2.17979868 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.16292472 |
| 17 | MP0005387_immune_system_phenotype | 2.14424499 |
| 18 | MP0001790_abnormal_immune_system | 2.14424499 |
| 19 | MP0003866_abnormal_defecation | 2.14258019 |
| 20 | MP0005166_decreased_susceptibility_to | 2.10240836 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 2.07677121 |
| 22 | MP0003436_decreased_susceptibility_to | 2.05529872 |
| 23 | MP0005409_darkened_coat_color | 1.89978620 |
| 24 | MP0003303_peritoneal_inflammation | 1.89722258 |
| 25 | MP0010352_gastrointestinal_tract_polyps | 1.77162599 |
| 26 | MP0004782_abnormal_surfactant_physiolog | 1.72543697 |
| 27 | MP0001800_abnormal_humoral_immune | 1.71942404 |
| 28 | MP0005025_abnormal_response_to | 1.69788833 |
| 29 | MP0005671_abnormal_response_to | 1.69527898 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.68174454 |
| 31 | MP0004858_abnormal_nervous_system | 1.62966616 |
| 32 | MP0009785_altered_susceptibility_to | 1.62609160 |
| 33 | MP0000490_abnormal_crypts_of | 1.58163626 |
| 34 | MP0001663_abnormal_digestive_system | 1.55694632 |
| 35 | MP0001664_abnormal_digestion | 1.52252159 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.47964880 |
| 37 | MP0005000_abnormal_immune_tolerance | 1.47362358 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.46594948 |
| 39 | MP0002166_altered_tumor_susceptibility | 1.44098592 |
| 40 | MP0009643_abnormal_urine_homeostasis | 1.42632852 |
| 41 | MP0010329_abnormal_lipoprotein_level | 1.42410265 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.40348837 |
| 43 | MP0000477_abnormal_intestine_morphology | 1.36093503 |
| 44 | MP0002876_abnormal_thyroid_physiology | 1.35380369 |
| 45 | MP0000678_abnormal_parathyroid_gland | 1.34240276 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.28384656 |
| 47 | MP0005381_digestive/alimentary_phenotyp | 1.26808085 |
| 48 | MP0002452_abnormal_antigen_presenting | 1.23755266 |
| 49 | MP0002148_abnormal_hypersensitivity_rea | 1.23193572 |
| 50 | MP0005332_abnormal_amino_acid | 1.21461550 |
| 51 | MP0002796_impaired_skin_barrier | 1.18557079 |
| 52 | MP0002723_abnormal_immune_serum | 1.16557614 |
| 53 | MP0003868_abnormal_feces_composition | 1.16131098 |
| 54 | MP0004947_skin_inflammation | 1.16063769 |
| 55 | MP0008004_abnormal_stomach_pH | 1.15719383 |
| 56 | MP0003763_abnormal_thymus_physiology | 1.13795705 |
| 57 | MP0002136_abnormal_kidney_physiology | 1.12962233 |
| 58 | MP0002420_abnormal_adaptive_immunity | 1.12326377 |
| 59 | MP0001819_abnormal_immune_cell | 1.11324654 |
| 60 | MP0005275_abnormal_skin_tensile | 1.08295427 |
| 61 | MP0000604_amyloidosis | 1.08045068 |
| 62 | MP0004147_increased_porphyrin_level | 1.06747746 |
| 63 | MP0005058_abnormal_lysosome_morphology | 1.05395640 |
| 64 | MP0006082_CNS_inflammation | 1.04849597 |
| 65 | MP0002419_abnormal_innate_immunity | 1.04549500 |
| 66 | MP0009333_abnormal_splenocyte_physiolog | 1.03967460 |
| 67 | MP0004043_abnormal_pH_regulation | 1.02695773 |
| 68 | MP0000249_abnormal_blood_vessel | 1.01654437 |
| 69 | MP0000462_abnormal_digestive_system | 1.01294395 |
| 70 | MP0008469_abnormal_protein_level | 0.95932205 |
| 71 | MP0000681_abnormal_thyroid_gland | 0.95616608 |
| 72 | MP0001756_abnormal_urination | 0.95231080 |
| 73 | MP0003329_amyloid_beta_deposits | 0.95204022 |
| 74 | MP0000538_abnormal_urinary_bladder | 0.93067904 |
| 75 | MP0002998_abnormal_bone_remodeling | 0.92259617 |
| 76 | MP0001765_abnormal_ion_homeostasis | 0.90646231 |
| 77 | MP0001764_abnormal_homeostasis | 0.89332263 |
| 78 | MP0002254_reproductive_system_inflammat | 0.89272631 |
| 79 | MP0003252_abnormal_bile_duct | 0.87434605 |
| 80 | MP0000716_abnormal_immune_system | 0.86300755 |
| 81 | MP0002933_joint_inflammation | 0.85130151 |
| 82 | MP0002971_abnormal_brown_adipose | 0.84775744 |
| 83 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.84656115 |
| 84 | MP0005451_abnormal_body_composition | 0.84602005 |
| 85 | MP0002118_abnormal_lipid_homeostasis | 0.83787920 |
| 86 | MP0005310_abnormal_salivary_gland | 0.83516047 |
| 87 | MP0003879_abnormal_hair_cell | 0.82750165 |
| 88 | MP0009764_decreased_sensitivity_to | 0.81515779 |
| 89 | MP0000609_abnormal_liver_physiology | 0.80379547 |
| 90 | MP0003075_altered_response_to | 0.79973897 |
| 91 | MP0002006_tumorigenesis | 0.78693143 |
| 92 | MP0004510_myositis | 0.77175978 |
| 93 | MP0001958_emphysema | 0.75612763 |
| 94 | MP0009115_abnormal_fat_cell | 0.72605840 |
| 95 | MP0005670_abnormal_white_adipose | 0.72444821 |
| 96 | MP0001501_abnormal_sleep_pattern | 0.72377493 |
| 97 | MP0005023_abnormal_wound_healing | 0.71737311 |
| 98 | MP0003448_altered_tumor_morphology | 0.71294727 |
| 99 | MP0005448_abnormal_energy_balance | 0.69712440 |
| 100 | MP0005535_abnormal_body_temperature | 0.69422346 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 7.85087831 |
| 2 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 6.79930955 |
| 3 | Malnutrition (HP:0004395) | 6.18878507 |
| 4 | Abnormality of complement system (HP:0005339) | 5.35631264 |
| 5 | Complement deficiency (HP:0004431) | 5.27369327 |
| 6 | Chronic diarrhea (HP:0002028) | 5.12644722 |
| 7 | Gastrointestinal stroma tumor (HP:0100723) | 4.95457012 |
| 8 | Glomerulonephritis (HP:0000099) | 4.77231372 |
| 9 | Abnormality of proline metabolism (HP:0010907) | 4.47972315 |
| 10 | Hydroxyprolinuria (HP:0003080) | 4.47972315 |
| 11 | Eczematoid dermatitis (HP:0000976) | 4.10953087 |
| 12 | Emphysema (HP:0002097) | 4.03355310 |
| 13 | Nephritis (HP:0000123) | 3.87217500 |
| 14 | Ileus (HP:0002595) | 3.28075989 |
| 15 | Vasculitis (HP:0002633) | 3.18807284 |
| 16 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.07881545 |
| 17 | Agammaglobulinemia (HP:0004432) | 2.99117320 |
| 18 | Recurrent bronchitis (HP:0002837) | 2.93779673 |
| 19 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.85650149 |
| 20 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.81678657 |
| 21 | Villous atrophy (HP:0011473) | 2.81678657 |
| 22 | Restrictive lung disease (HP:0002091) | 2.81546410 |
| 23 | Xanthomatosis (HP:0000991) | 2.79408250 |
| 24 | Decreased circulating renin level (HP:0003351) | 2.79217324 |
| 25 | Hypobetalipoproteinemia (HP:0003563) | 2.78327496 |
| 26 | Fat malabsorption (HP:0002630) | 2.77750599 |
| 27 | Hemorrhage of the eye (HP:0011885) | 2.63532675 |
| 28 | Abnormality of vitamin B metabolism (HP:0004340) | 2.63526159 |
| 29 | Widely patent fontanelles and sutures (HP:0004492) | 2.63449732 |
| 30 | Congenital sensorineural hearing impairment (HP:0008527) | 2.61784588 |
| 31 | Lymphopenia (HP:0001888) | 2.55425338 |
| 32 | Abnormality of the nasal mucosa (HP:0000433) | 2.54995638 |
| 33 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.53381014 |
| 34 | Pustule (HP:0200039) | 2.50945932 |
| 35 | Cerebral palsy (HP:0100021) | 2.46481380 |
| 36 | Increased IgE level (HP:0003212) | 2.45905443 |
| 37 | Gingivitis (HP:0000230) | 2.45046246 |
| 38 | Meningitis (HP:0001287) | 2.41990384 |
| 39 | Colitis (HP:0002583) | 2.40964181 |
| 40 | Alkalosis (HP:0001948) | 2.36708825 |
| 41 | Spontaneous hematomas (HP:0007420) | 2.36545469 |
| 42 | Metabolic alkalosis (HP:0200114) | 2.32638494 |
| 43 | Thin bony cortex (HP:0002753) | 2.31624339 |
| 44 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.31037098 |
| 45 | Hypophosphatemia (HP:0002148) | 2.30703775 |
| 46 | IgA deficiency (HP:0002720) | 2.29993613 |
| 47 | Nausea (HP:0002018) | 2.28866896 |
| 48 | Purpura (HP:0000979) | 2.23458383 |
| 49 | Skin rash (HP:0000988) | 2.23312050 |
| 50 | Confusion (HP:0001289) | 2.22093164 |
| 51 | Growth hormone excess (HP:0000845) | 2.21232893 |
| 52 | Cellulitis (HP:0100658) | 2.21104467 |
| 53 | Wide cranial sutures (HP:0010537) | 2.19883404 |
| 54 | Abnormality of vitamin metabolism (HP:0100508) | 2.18378356 |
| 55 | Chronic otitis media (HP:0000389) | 2.17320584 |
| 56 | Hyperparathyroidism (HP:0000843) | 2.16916043 |
| 57 | Premature loss of primary teeth (HP:0006323) | 2.16519671 |
| 58 | Abdominal distention (HP:0003270) | 2.14789903 |
| 59 | Potter facies (HP:0002009) | 2.12833199 |
| 60 | Facial shape deformation (HP:0011334) | 2.12833199 |
| 61 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.11353249 |
| 62 | Chronic obstructive pulmonary disease (HP:0006510) | 2.10887210 |
| 63 | Obstructive lung disease (HP:0006536) | 2.10887210 |
| 64 | Inflammation of the large intestine (HP:0002037) | 2.09853075 |
| 65 | Posterior subcapsular cataract (HP:0007787) | 2.06928783 |
| 66 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.05545916 |
| 67 | Hemoptysis (HP:0002105) | 2.05363920 |
| 68 | Gastrointestinal inflammation (HP:0004386) | 2.03833055 |
| 69 | Osteomyelitis (HP:0002754) | 2.03062699 |
| 70 | Nephrolithiasis (HP:0000787) | 2.02569171 |
| 71 | Pulmonary infiltrates (HP:0002113) | 2.01449788 |
| 72 | Pigmentary retinal degeneration (HP:0001146) | 2.01271224 |
| 73 | Steatorrhea (HP:0002570) | 2.00304673 |
| 74 | Gastrointestinal dysmotility (HP:0002579) | 1.99639482 |
| 75 | Hyperactive renin-angiotensin system (HP:0000841) | 1.97209086 |
| 76 | Nasal polyposis (HP:0100582) | 1.97122774 |
| 77 | Panhypogammaglobulinemia (HP:0003139) | 1.95256000 |
| 78 | Abnormality of macrophages (HP:0004311) | 1.92607028 |
| 79 | Abnormality of renin-angiotensin system (HP:0000847) | 1.92048681 |
| 80 | Recurrent sinusitis (HP:0011108) | 1.90679358 |
| 81 | Pancreatitis (HP:0001733) | 1.88525843 |
| 82 | Hyperglycinuria (HP:0003108) | 1.86780573 |
| 83 | Abnormality of urine glucose concentration (HP:0011016) | 1.85148408 |
| 84 | Glycosuria (HP:0003076) | 1.85148408 |
| 85 | Hypotension (HP:0002615) | 1.84857640 |
| 86 | Acanthocytosis (HP:0001927) | 1.81621282 |
| 87 | Right ventricular cardiomyopathy (HP:0011663) | 1.81173345 |
| 88 | Rectal prolapse (HP:0002035) | 1.79077197 |
| 89 | Gastrointestinal infarctions (HP:0005244) | 1.78254511 |
| 90 | Hyperuricemia (HP:0002149) | 1.78163158 |
| 91 | Increased purine levels (HP:0004368) | 1.78163158 |
| 92 | Focal segmental glomerulosclerosis (HP:0000097) | 1.75744347 |
| 93 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.75462411 |
| 94 | Hyperlipoproteinemia (HP:0010980) | 1.74769291 |
| 95 | Verrucae (HP:0200043) | 1.72830329 |
| 96 | Papilloma (HP:0012740) | 1.72830329 |
| 97 | Abnormal glucose tolerance (HP:0001952) | 1.72465523 |
| 98 | Amyloidosis (HP:0011034) | 1.72123848 |
| 99 | Hyperphosphatemia (HP:0002905) | 1.71970676 |
| 100 | Encephalitis (HP:0002383) | 1.71106869 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 6.07682408 |
| 2 | ACVR1B | 3.54738976 |
| 3 | MAP4K1 | 3.51921158 |
| 4 | RIPK1 | 3.22869228 |
| 5 | FGFR4 | 3.13440011 |
| 6 | MST1R | 3.09273034 |
| 7 | TYK2 | 2.81554567 |
| 8 | EPHA3 | 2.33140656 |
| 9 | PRKG2 | 2.28826595 |
| 10 | MAP3K10 | 2.21599693 |
| 11 | EPHA2 | 1.95609884 |
| 12 | PRPF4B | 1.91369869 |
| 13 | EPHB1 | 1.79661339 |
| 14 | RIPK4 | 1.77241751 |
| 15 | EPHB2 | 1.72318993 |
| 16 | CDC42BPA | 1.71125939 |
| 17 | TRIB3 | 1.68563104 |
| 18 | JAK3 | 1.66495953 |
| 19 | MYLK | 1.59265756 |
| 20 | FGFR3 | 1.55514140 |
| 21 | TBK1 | 1.48383481 |
| 22 | IKBKE | 1.47677093 |
| 23 | PTK6 | 1.43863573 |
| 24 | GRK6 | 1.40512191 |
| 25 | ZAP70 | 1.40019706 |
| 26 | JAK1 | 1.35617409 |
| 27 | MAP3K1 | 1.34534333 |
| 28 | MAP3K14 | 1.33652527 |
| 29 | DDR2 | 1.29785150 |
| 30 | MAP2K2 | 1.24342853 |
| 31 | TESK1 | 1.23115722 |
| 32 | TESK2 | 1.22758060 |
| 33 | KIT | 1.19366919 |
| 34 | DMPK | 1.18297624 |
| 35 | BLK | 1.17101908 |
| 36 | NLK | 1.15903094 |
| 37 | MAP3K11 | 1.08723484 |
| 38 | TGFBR2 | 1.08281709 |
| 39 | BTK | 1.06602942 |
| 40 | CSF1R | 1.05341332 |
| 41 | CSK | 0.98676035 |
| 42 | MET | 0.96431998 |
| 43 | SYK | 0.92754429 |
| 44 | SMG1 | 0.90381130 |
| 45 | KDR | 0.88912047 |
| 46 | MAP3K13 | 0.87446181 |
| 47 | MATK | 0.83897159 |
| 48 | LRRK2 | 0.83391059 |
| 49 | JAK2 | 0.80091690 |
| 50 | FER | 0.80005220 |
| 51 | LYN | 0.78617901 |
| 52 | PDGFRA | 0.77507858 |
| 53 | STK24 | 0.76745906 |
| 54 | HIPK2 | 0.76320157 |
| 55 | PDPK1 | 0.72133394 |
| 56 | LCK | 0.71295680 |
| 57 | ITK | 0.70913429 |
| 58 | TAOK1 | 0.69225371 |
| 59 | SIK3 | 0.66656800 |
| 60 | STK39 | 0.65425274 |
| 61 | MAP3K2 | 0.64648954 |
| 62 | ERBB2 | 0.63103317 |
| 63 | SIK1 | 0.62684623 |
| 64 | TXK | 0.62414087 |
| 65 | MAP3K12 | 0.61415282 |
| 66 | MAPK7 | 0.60210169 |
| 67 | CDK19 | 0.59620003 |
| 68 | RET | 0.59611533 |
| 69 | BMX | 0.58546093 |
| 70 | PIK3CA | 0.57883000 |
| 71 | IRAK1 | 0.56775023 |
| 72 | FYN | 0.55958063 |
| 73 | FES | 0.55941325 |
| 74 | OXSR1 | 0.53905667 |
| 75 | MAPK11 | 0.53022181 |
| 76 | TEC | 0.52911229 |
| 77 | DYRK1B | 0.52763747 |
| 78 | PRKD2 | 0.50391927 |
| 79 | IRAK4 | 0.49441472 |
| 80 | TNK2 | 0.49165213 |
| 81 | PDK1 | 0.48938615 |
| 82 | IKBKB | 0.48253749 |
| 83 | MAP3K3 | 0.46922767 |
| 84 | SRC | 0.46916792 |
| 85 | MAPKAPK2 | 0.44620071 |
| 86 | HCK | 0.43341287 |
| 87 | PRKACG | 0.41717981 |
| 88 | RPS6KA2 | 0.41328033 |
| 89 | PRKAA2 | 0.41103772 |
| 90 | RPS6KL1 | 0.37800363 |
| 91 | RPS6KC1 | 0.37800363 |
| 92 | MAP3K7 | 0.35890877 |
| 93 | PRKCQ | 0.35675116 |
| 94 | PKN2 | 0.33654172 |
| 95 | PRKCA | 0.32389561 |
| 96 | PRKCZ | 0.32211141 |
| 97 | MAP2K6 | 0.32148770 |
| 98 | MAPK4 | 0.32004260 |
| 99 | PAK4 | 0.31579229 |
| 100 | CDK6 | 0.31519818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 4.02896746 |
| 2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.55088518 |
| 3 | Asthma_Homo sapiens_hsa05310 | 3.43030738 |
| 4 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.00024359 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.99932341 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.92611131 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.89808770 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.87206793 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.62689012 |
| 10 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.48391630 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.17263189 |
| 12 | Histidine metabolism_Homo sapiens_hsa00340 | 2.03274541 |
| 13 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.98292700 |
| 14 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.97030206 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.96900003 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.81361857 |
| 17 | Mineral absorption_Homo sapiens_hsa04978 | 1.77233345 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.77162633 |
| 19 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.72882012 |
| 20 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.66918036 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.61197386 |
| 22 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.61194687 |
| 23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.55206337 |
| 24 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.37274328 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.34215883 |
| 26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.23752696 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.23419142 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.21776826 |
| 29 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.19327123 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.19137880 |
| 31 | Pertussis_Homo sapiens_hsa05133 | 1.18900798 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.17448353 |
| 33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.16901960 |
| 34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.15498832 |
| 35 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.11581886 |
| 36 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.10124235 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08083617 |
| 38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.06639230 |
| 39 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.05913513 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.03766228 |
| 41 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.03431981 |
| 42 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.03392162 |
| 43 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.01295174 |
| 44 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.01182910 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00343099 |
| 46 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.99822132 |
| 47 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.98989533 |
| 48 | Galactose metabolism_Homo sapiens_hsa00052 | 0.92216436 |
| 49 | Bile secretion_Homo sapiens_hsa04976 | 0.87235782 |
| 50 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.86233197 |
| 51 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86121583 |
| 52 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.85740642 |
| 53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.85031635 |
| 54 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.83731153 |
| 55 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.77380251 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.73229521 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 0.72695247 |
| 58 | Tuberculosis_Homo sapiens_hsa05152 | 0.72336103 |
| 59 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.71922631 |
| 60 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.69012886 |
| 61 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67096957 |
| 62 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.65307055 |
| 63 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.64687892 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63772574 |
| 65 | Prion diseases_Homo sapiens_hsa05020 | 0.62643901 |
| 66 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.61562882 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.60619977 |
| 68 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.55119932 |
| 69 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.54275631 |
| 70 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.52692847 |
| 71 | Phagosome_Homo sapiens_hsa04145 | 0.52072071 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.50966076 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50154334 |
| 74 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.47016294 |
| 75 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.42836864 |
| 76 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.42745954 |
| 77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41064390 |
| 78 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.40607865 |
| 79 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.38729553 |
| 80 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37969852 |
| 81 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.36154766 |
| 82 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.34727557 |
| 83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34232854 |
| 84 | Renin secretion_Homo sapiens_hsa04924 | 0.32692597 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.31610605 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.30589373 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | 0.28206692 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25125594 |
| 89 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.23679689 |
| 90 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.22935415 |
| 91 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.20192451 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.17597004 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.13397117 |
| 94 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.12317817 |
| 95 | Lysosome_Homo sapiens_hsa04142 | 0.12311475 |
| 96 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.12247712 |
| 97 | Salmonella infection_Homo sapiens_hsa05132 | 0.11640553 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.11108544 |
| 99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.10020655 |
| 100 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.08466836 |

